[{"address1": "321 Arsenal Street", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "339 217 0161", "website": "https://www.iteostherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), as well as engages the Fc gamma receptor to activate dendritic cells, natural killer cells, T lymphocytes, and macrophages and to promote the release of cytotoxic granules and antibody-dependent cellular cytotoxicity activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonist program; EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to reverse immunosuppression and restore T cell proliferation in the tumor microenvironment; and EOS-215, a monoclonal antibody which antagonizes triggering receptor expressed on triggering receptor expressed on myeloid cells 2. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 173, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michel  Detheux Ph.D.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 1043774, "exercisedValue": 0, "unexercisedValue": 4750180}, {"maxAge": 1, "name": "Mr. Matthew  Gall", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 648001, "exercisedValue": 0, "unexercisedValue": 1259823}, {"maxAge": 1, "name": "Mr. Matthew A. Call M.B.A.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 706214, "exercisedValue": 0, "unexercisedValue": 1848175}, {"maxAge": 1, "name": "Dr. Yvonne  McGrath Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Adi  Osovsky", "title": "Executive Vice President of Legal", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe  Brantegem", "title": "Executive Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Feltquate M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.885, "open": 6.82, "dayLow": 6.72, "dayHigh": 6.8974, "regularMarketPreviousClose": 6.885, "regularMarketOpen": 6.82, "regularMarketDayLow": 6.72, "regularMarketDayHigh": 6.8974, "payoutRatio": 0.0, "beta": 1.382, "forwardPE": -1.1760684, "volume": 402878, "regularMarketVolume": 402878, "averageVolume": 322201, "averageVolume10days": 424450, "averageDailyVolume10Day": 424450, "bid": 4.94, "ask": 8.61, "bidSize": 2, "askSize": 2, "marketCap": 262776784, "fiftyTwoWeekLow": 6.67, "fiftyTwoWeekHigh": 18.75, "priceToSalesTrailing12Months": 7.5079083, "fiftyDayAverage": 7.3931, "twoHundredDayAverage": 11.060325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -226774928, "profitMargins": 0.0, "floatShares": 29147629, "sharesOutstanding": 38194300, "sharesShort": 1280718, "sharesShortPriorMonth": 1405639, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0335, "heldPercentInsiders": 0.0113, "heldPercentInstitutions": 0.91183, "shortRatio": 5.23, "shortPercentOfFloat": 0.060500003, "impliedSharesOutstanding": 38222100, "bookValue": 16.142, "priceToBook": 0.42621732, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -134414000, "trailingEps": -3.32, "forwardEps": -5.85, "enterpriseToRevenue": -6.479, "enterpriseToEbitda": 1.458, "52WeekChange": -0.39383262, "SandP52WeekChange": 0.086116076, "quoteType": "EQUITY", "currentPrice": 6.88, "targetHighPrice": 47.0, "targetLowPrice": 15.0, "targetMeanPrice": 25.0, "targetMedianPrice": 21.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 494648000, "totalCashPerShare": 12.951, "ebitda": -155571008, "totalDebt": 5096000, "quickRatio": 12.347, "currentRatio": 12.625, "totalRevenue": 35000000, "debtToEquity": 0.863, "revenuePerShare": 0.865, "returnOnAssets": -0.1447, "returnOnEquity": -0.23065001, "grossProfits": 35000000, "freeCashflow": -64353624, "operatingCashflow": -98181000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -4.48026, "financialCurrency": "USD", "symbol": "ITOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 0.436043, "postMarketPrice": 6.91, "postMarketChange": 0.0299997, "regularMarketChange": -0.0050001144, "regularMarketDayRange": "6.72 - 6.8974", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 322201, "fiftyTwoWeekLowChange": 0.21000004, "fiftyTwoWeekLowChangePercent": 0.031484265, "fiftyTwoWeekRange": "6.67 - 18.75", "fiftyTwoWeekHighChange": -11.87, "fiftyTwoWeekHighChangePercent": -0.63306665, "fiftyTwoWeekChangePercent": -39.383263, "earningsTimestamp": 1741176000, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.32, "epsForward": -5.85, "epsCurrentYear": -3.77294, "priceEpsCurrentYear": -1.8235117, "fiftyDayAverageChange": -0.5130997, "fiftyDayAverageChangePercent": -0.06940251, "twoHundredDayAverageChange": -4.1803246, "twoHundredDayAverageChangePercent": -0.37795678, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-24", "averageAnalystRating": "1.4 - Strong Buy", "shortName": "iTeos Therapeutics, Inc.", "longName": "iTeos Therapeutics, Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1595597400000, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1742589056, "regularMarketTime": 1742587202, "exchange": "NGM", "messageBoardId": "finmb_663087242", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.0726233, "regularMarketPrice": 6.88, "displayName": "iTeos Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-22"}]